These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 26434630

  • 1. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
    Hu M, Li K, Maskey N, Xu Z, Yu F, Peng C, Li Y, Yang G.
    Hum Pathol; 2015 Dec; 46(12):1872-80. PubMed ID: 26434630
    [Abstract] [Full Text] [Related]

  • 2. Impact of chemokine receptor CXCR3 on tumor-infiltrating lymphocyte recruitment associated with favorable prognosis in advanced gastric cancer.
    Li K, Zhu Z, Luo J, Fang J, Zhou H, Hu M, Maskey N, Yang G.
    Int J Clin Exp Pathol; 2015 Dec; 8(11):14725-32. PubMed ID: 26823797
    [Abstract] [Full Text] [Related]

  • 3. Expression of the Chemokine Receptor CXCR3 Correlates with Dendritic Cell Recruitment and Prognosis in Gastric Cancer.
    Chen F, Yin S, Niu L, Luo J, Wang B, Xu Z, Yang G.
    Genet Test Mol Biomarkers; 2018 Jan; 22(1):35-42. PubMed ID: 29266971
    [Abstract] [Full Text] [Related]

  • 4. Low level of FOXL1 indicates a worse prognosis for gastric cancer patients.
    Ertao Z, Jianhui C, Chuangqi C, Changjiang Q, Sile C, Yulong H, Shirong C, Hui W.
    Tumour Biol; 2016 Aug; 37(8):11331-7. PubMed ID: 26960689
    [Abstract] [Full Text] [Related]

  • 5. Chemokine Receptor CXCR3 Correlates with Decreased M2 Macrophage Infiltration and Favorable Prognosis in Gastric Cancer.
    Chen F, Yuan J, Yan H, Liu H, Yin S.
    Biomed Res Int; 2019 Aug; 2019():6832867. PubMed ID: 31240220
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C, Wen Y, Li H, Zhang D, Zhang N, Shi X, Jiang B, Ma X, Yang P, Tang H, Peng Z, Yang Y.
    Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
    [Abstract] [Full Text] [Related]

  • 7. Elevated Levels of SET and MYND Domain-Containing Protein 3 Are Correlated with Overexpression of Transforming Growth Factor-β1 in Gastric Cancer.
    Liu H, Liu Y, Kong F, Xin W, Li X, Liang H, Jia Y.
    J Am Coll Surg; 2015 Aug; 221(2):579-90. PubMed ID: 26077602
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients.
    Min L, Ruan Y, Shen Z, Jia D, Wang X, Zhao J, Sun Y, Gu J.
    Histopathology; 2015 Nov; 67(5):677-88. PubMed ID: 25809930
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancer.
    Liu Y, Deng J, Luo X, Pan Y, Zhang L, Zhang R, Liang H.
    Med Oncol; 2015 Jan; 32(1):404. PubMed ID: 25471787
    [Abstract] [Full Text] [Related]

  • 10. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
    Sato Y, Inokuchi M, Takagi Y, Otsuki S, Fujimori Y, Yanaka Y, Kobayashi K, Higuchi K, Kojima K, Kawano T.
    J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of mixed lineage kinase domain-like protein expression in the survival of patients with gastric caner.
    Ertao Z, Jianhui C, Kang W, Zhijun Y, Hui W, Chuangqi C, Changjiang Q, Sile C, Yulong H, Shirong C.
    Tumour Biol; 2016 Oct; 37(10):13679-13685. PubMed ID: 27473085
    [Abstract] [Full Text] [Related]

  • 12. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
    Shi R, Wang L, Wang T, Xu J, Wang F, Xu M.
    Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of HOXA10 promotes gastric cancer cells proliferation and HOXA10(+)/CD44(+) is potential prognostic biomarker for gastric cancer.
    Han Y, Lu S, Wen YG, Yu FD, Zhu XW, Qiu GQ, Tang HM, Peng ZH, Zhou CZ.
    Eur J Cell Biol; 2015 Dec; 94(12):642-52. PubMed ID: 26552644
    [Abstract] [Full Text] [Related]

  • 14. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
    Zhou Z, Xie J, Cai Y, Yang S, Chen Y, Wu H.
    Diagn Pathol; 2015 Jul 28; 10():128. PubMed ID: 26215716
    [Abstract] [Full Text] [Related]

  • 15. Decreased Muc5AC expression is associated with poor prognosis in gastric cancer.
    Kim SM, Kwon CH, Shin N, Park DY, Moon HJ, Kim GH, Jeon TY.
    Int J Cancer; 2014 Jan 01; 134(1):114-24. PubMed ID: 23801416
    [Abstract] [Full Text] [Related]

  • 16. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
    Wang CY, Hua L, Yao KH, Chen JT, Zhang JJ, Hu JH.
    Int J Clin Exp Pathol; 2015 Jan 01; 8(1):779-85. PubMed ID: 25755774
    [Abstract] [Full Text] [Related]

  • 17. Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: its molecular mechanism was investigated using artificial microRNA interference.
    Wang Z, He YL, Cai SR, Zhan WH, Li ZR, Zhu BH, Chen CQ, Ma JP, Chen ZX, Li W, Zhang LJ.
    Int J Cancer; 2008 Sep 15; 123(6):1439-47. PubMed ID: 18561324
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Upregulation of GPR34 expression affects the progression and prognosis of human gastric adenocarcinoma by PI3K/PDK1/AKT pathway.
    Yu W, Ma S, Wang L, Zuo B, Li M, Qiao Z, Pan X, Liu Y, Wang J.
    Histol Histopathol; 2013 Dec 15; 28(12):1629-38. PubMed ID: 23836308
    [Abstract] [Full Text] [Related]

  • 20. Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.
    Tang C, Gao X, Liu H, Jiang T, Zhai X.
    Int J Clin Exp Pathol; 2014 Dec 15; 7(8):4782-94. PubMed ID: 25197349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.